Straits Times Index
3,084.08 -6.23 (-0.20%) S&P 500
4,570.87 -23.76 (-0.52%) Dow
36,223.50 -22.00 (-0.06%) Nasdaq
14,186.17 -118.86 (-0.83%) Bitcoin USD
41,785.92 +2,199.20 (+5.56%) CMC Crypto 200
859.31 +0.60 (+0.07%)
Inogen Inc (6IO.SG)
| Previous close | 5.20 |
| Open | 5.15 |
| Bid | 5.15 x 200000 |
| Ask | 5.30 x 200000 |
| Day's range | 5.15 - 5.30 |
| 52-week range | 3.92 - 24.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
GOLETA, Calif., November 13, 2023--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Kevin Smith as Inogen’s President and Chief Executive Officer and a member of the Board of Directors, effective immediately, succeeding Nabil Shabshab.
- Business Wire
Inogen to Present at Upcoming Investor Conferences in November 2023
GOLETA, Calif., November 09, 2023--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
- Business Wire
Inogen Announces Third Quarter 2023 Financial Results
GOLETA, Calif., November 07, 2023--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2023.
